Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

Intensive Care Medicine
Corinne AlbertiRoger Le Gall

Abstract

To examine the incidence of infections and to describe them and their outcome in intensive care unit (ICU) patients. International prospective cohort study in which all patients admitted to the 28 participating units in eight countries between May 1997 and May 1998 were followed until hospital discharge. A total of 14,364 patients were admitted to the ICUs, 6011 of whom stayed less than 24 h and 8353 more than 24 h. Overall 3034 infectious episodes were recorded at ICU admission (crude incidence: 21.1%). In ICU patients hospitalised longer than 24 h there were 1581 infectious episodes (crude incidence: 18.9%) including 713 (45%) in patients already infected at ICU admission. These rates varied between ICUs. Respiratory, digestive, urinary tracts, and primary bloodstream infections represented about 80% of all sites. Hospital-acquired and ICU-acquired infections were documented more frequently microbiologically than community-acquired infections (71% and 86%, respectively vs. 55%). About 28% of infections were associated with sepsis, 24% with severe sepsis and 30% with septic shock, and 18% were not classified. Crude hospital mortality rates ranged from 16.9% in non-infected patients to 53.6% in patients with hospital-acquired i...Continue Reading

Citations

Mar 1, 2004·Environmental Health and Preventive Medicine·Machi SukaJun Takezawa
Feb 22, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·H Ebelt, K Werdan
Jul 1, 2006·Der Anaesthesist·M BauerK Reinhart
May 11, 2006·Der Anaesthesist·O Moerer, H Burchardi
Feb 27, 2007·Intensive Care Medicine·Christoph EngelKonrad Reinhart
Jul 10, 2007·Intensive Care Medicine·Michael D HowellNathan I Shapiro
Dec 7, 2007·Intensive Care Medicine·Rui P MorenoUNKNOWN SAPS 3 Investigators
Feb 9, 2008·Intensive Care Medicine·Pierre DamasJean-Charles Preiser
Feb 9, 2008·Intensive Care Medicine·Christian Brun-Buisson
Mar 28, 2008·Intensive Care Medicine·Jean-Pierre QuenotUNKNOWN TECLA Study Group
Sep 23, 2008·Intensive Care Medicine·Rosanna VaschettoAnnalisa Chiocchetti
Feb 10, 2010·Intensive Care Medicine·Matti ReinikainenVille Pettilä
Jul 9, 2010·Intensive Care Medicine·Heinz BurgmannPhilipp G H Metnitz
May 27, 2011·Intensive Care Medicine·Pierre DamasDidier Ledoux
Jan 30, 2013·Intensive Care Medicine·Nicolas NesselerPhilippe Seguin
Jul 27, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·K ReinhartK Werdan
Sep 8, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Katy M HanzelkaTerry W Rice
Oct 26, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A J M LoonenA J C van den Brule
Dec 15, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S SanchoJ M Nogueira
Jul 9, 2008·Inflammation·Ahmet TekinAdil Kartal
May 22, 2008·Pharmacy World & Science : PWS·Hui DingXuzhuang Shen
Oct 10, 2013·International Journal of Clinical Pharmacy·Lama NazerFeras Hawari
Sep 6, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Craig R WeinertSabita Roy
Aug 19, 2005·Current Infectious Disease Reports·Pajman Danai, Greg S Martin
Aug 29, 2006·Current Infectious Disease Reports·Rui MorenoTeresa Fevereiro
Aug 9, 2011·Current Infectious Disease Reports·John D Dickinson, Marin H Kollef
Aug 21, 2013·Current Infectious Disease Reports·Hugues MarechalPierre Damas
Aug 21, 2010·Journal of Physiology and Biochemistry·Miroslav KovarikMilan Holecek
Jun 15, 2005·Pulmonary Pharmacology & Therapeutics·Oguz KokselArzu Kanik
Feb 24, 2006·Epidemiology and Infection·M D TanrioverO Uzun
Sep 26, 2007·Epidemiology and Infection·M E FalagasK Z Vardakas
Dec 20, 2002·Nature·Jonathan Cohen
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Sep 30, 2005·The New England Journal of Medicine·Edward AbrahamUNKNOWN Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group
Aug 10, 2006·Surgical Infections·Gianfranco Donelli
Dec 29, 2009·European Heart Journal·Claudio RoncoUNKNOWN Acute Dialysis Quality Initiative (ADQI) consensus group
Mar 31, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Maryam NejatZoltán H Endre
Jan 29, 2008·Journal of Tropical Pediatrics·Hui DingXuzhuang Shen
Mar 31, 2011·Journal of Tropical Pediatrics·G J Ebrahim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.